Table 4.
Non-susceptibility rates of the most prevalent bacterial pathogens from bloodstream infections in Gabon
| Pathogen (n) |
Antimicrobial non-susceptibility (%) |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PEN/AMPa | COX | AMP + BLI | CRO | GEN | CIP | CHL | CLI | ERY | SXT | TCY | |
|
S. aureus (30) |
89.7 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
10 |
7.8 |
66.7 |
|
S. pyogenes (3) |
0 |
- |
- |
0 |
- |
- |
ND |
0 |
0 |
0 |
- |
|
S. pneumoniae (15) |
25 |
- |
- |
25 |
- |
- |
33.3 |
14.3 |
13.3 |
71.4 |
ND |
|
K. pneumoniae (29) |
100 |
- |
92.6 |
74.1 |
75 |
37.9 |
100 |
- |
- |
96.3 |
ND |
|
P. agglomerans (11) |
90.9 |
- |
81.8 |
80 |
45.4 |
18.2 |
50 |
- |
- |
80 |
ND |
|
E. coli (16) |
81.2 |
- |
62.5 |
0 |
6.3 |
12.5 |
66.7 |
- |
- |
81.2 |
ND |
| S. enterica (26) | 3.9 | - | 3.9 | 3.9 | 0 | 0 | 11.1 | - | - | 4 | 0 |
Note: Abbrevations are penicillin/ampicillin (PEN/AMP), cefoxitin (COX), ampicillin plus betalactamase-inhibitor (AMP + BLI), ceftriaxone (CRO), gentamicin (GEN), ciprofloxacin (CIP), chloramphenicol (CHL), clindamycin (CLI), erythromycin (ERY), cotrimoxazole (SXT), tetracycline (TCY), not done (ND). Non-susceptible isolates are shown as the percentage of tested isolates. Data from P. aeruginosa and P. mirabilis were not reported due to small sample size (n = 2).
aShown is the non-susceptibility of Gram-positives to penicillin and the non-susceptibility of Gram-negatives to ampicillin.